Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

      NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

      Medical Dialogues Bureau14 Nov 2019 11:30 AM IST
      New Delhi: Through a recent order, the apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) has exempted drugmaker, Sun...
      Eli Lilly-Boehringer diabetes drug Empagliflozin gets thumbs down from FDA panel

      Eli Lilly-Boehringer diabetes drug Empagliflozin gets thumbs down from FDA panel

      Medical Dialogues Bureau14 Nov 2019 9:45 AM IST
      Empagliflozin belongs to a class of drugs called SGLT2 inhibitors, like Johnson & Johnson's Invokana and AstraZeneca Plc's Farxiga, which lower...
      Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

      Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

      Medical Dialogues Bureau14 Nov 2019 9:30 AM IST
      Managing director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
      Mediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediator

      Mediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediator

      Medical Dialogues Bureau14 Nov 2019 9:00 AM IST
      Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other...
      Health Insurance- The Best Backup Plan in Today

      Health Insurance- The Best Backup Plan in Today's Times

      Medical Dialogues Bureau13 Nov 2019 11:44 AM IST
      Healthcare delivery sector is advancing at a lightening pace with doctors now capable to threatening many threatening diseases that earlier were...
      Bristol-Myers Opdivo, Yervoy combination gets USFDA priority review for advanced HCC

      Bristol-Myers Opdivo, Yervoy combination gets USFDA priority review for advanced HCC

      Medical Dialogues Bureau13 Nov 2019 10:00 AM IST
      New Delhi: Bristol-Myers Squibb Company recently announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics...
      Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

      Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

      Medical Dialogues Bureau13 Nov 2019 9:33 AM IST
      "The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
      Owlstone Medical collaborates with Thermo Fisher Scientific to advance use of breath samples to detect disease

      Owlstone Medical collaborates with Thermo Fisher Scientific to advance use of breath samples to detect disease

      Medical Dialogues Bureau13 Nov 2019 9:32 AM IST
      Cambridge: Owlstone Medical, recently announced it has partnered with Thermo Fisher Scientific. The collaboration seeks to advance the application of...
      Changsheng Life Sciences declared bankrupt in vaccine scandal

      Changsheng Life Sciences declared bankrupt in vaccine scandal

      Medical Dialogues Bureau13 Nov 2019 9:00 AM IST
      Changsheng Life Sciences used expired materials, mixed different batches of products and failed to test them properly, according to regulators. They...
      Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore

      Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore

      Medical Dialogues Bureau12 Nov 2019 4:46 PM IST
      As per a recent release by Lupin, the proposed transaction values Kyowa at an enterprise value of JPY 57,361 million (~INR 37,024 million) and will...
      Glenmark gets USFDA nod for generic version of Epiduo gel to treat acute acne

      Glenmark gets USFDA nod for generic version of Epiduo gel to treat acute acne

      Medical Dialogues Bureau12 Nov 2019 12:04 PM IST
      The approval granted to Glenmark Pharmaceuticals Inc by the US Food and Drug Administration is for Adapalene and Benzoyl Peroxide Gel, 0.1 per...
      Mega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 crore

      Mega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 crore

      Medical Dialogues Bureau12 Nov 2019 9:45 AM IST
      Novartis's Sandoz generics business agreed to pay 300 million euros initially, plus a deferred amount not expected to exceed 100 million euros based...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok